Document Detail


Tenascin and cytokines in tear fluid after photorefractive keratectomy.
MedLine Citation:
PMID:  9699169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Basic knowledge of the substances involved in wound healing after photorefractive keratectomy (PRK) is essential for development of pharmacological intervention. We present preoperative and postoperative analysis of tear fluid extracellular matrix proteins and cytokines after PRK. METHODS: Tear fluid samples from 70 patients (72 eyes) who had PRK (38 women and 32 men, mean age 31.5 yr) were studied. Samples from 18 patients (18 eyes) were analyzed in two different studies. RESULTS: Mean preoperative tear fluid flow in the collection capillary (volume divided by tear collection time) varied from 4.5 to 22.5 microliters/min in five series of patients. It increased significantly during the first two postoperative days (range of means, 55.5 to 88.8 microliters/min, p < 0.01), and decreased to the preoperative level by day 7 (range of means, 9.7 to 18.2 microliters/min). The tenascin and cytokine release rates increased significantly during the first two days after PRK and returned to the preoperative level by day 7. Mean +/- standard error for tenascin: day 0 (5.2 +/- 1.9 ng/min); day 2 (22.7 +/- 6.1 ng/min; p = 0.02). Mean +/- standard error for HGF: day 0 (3.2 +/- 0.7 pg/min); day 1 (22.8 +/- 4.2 pg/min; p = 0.0003). Mean +/- standard error for TGF-beta 1: day 0 (63.3 +/- 19.6 pg/min); days 1-2 (826.2 +/- 253.7 pg/min; p = 0.001). Mean +/- standard error for VEGF: day 0 (166.0 +/- 29.6 pg/min); days 1-2 (824.4 +/- 165.1 pg/min; p = 0.0007). Mean +/- standard error for PDGF-BB: day 0 (0.42 +/- 0.19 pg/min); day 2 (27.6 +/- 5.8 pg/min; p = 0.0000). Mean +/- standard error for TNF-alpha: day 0 (9.5 +/- 2.6 pg/min); day 2 (28.6 +/- 5.9 pg/min; p = 0.003). Excluding PDGF-BB, all substances studied were present in normal human tear fluid. PDGF-BB was present in only 17% of the preoperative samples. CONCLUSION: Corneal wounding induces an increased release of several growth modulating cytokines which may be involved in healing processes.
Authors:
M H Vesaluoma; T T Tervo
Related Documents :
17589379 - Glibenclamide dose response in patients with septic shock: effects on norepinephrine re...
3667009 - Effect of verapamil on pulmonary function changes induced by fluid overloading in norma...
16454639 - Influence of gastrointestinal tract disease on pharmacokinetics of lidocaine after intr...
12635879 - Mechanisms responsible for vasodilation upon magnesium infusion in vivo: clinical evide...
3354869 - Is milrinone equivalent to amrinone during enflurane anesthesia in the dog?
2464099 - Atrial natriuretic peptide administered as intravenous infusion or bolus injection to p...
578729 - The influence of intravenous injection of lidocaine on optokinetic nystagmus in rabbits.
9728739 - Consideration on a limit for lifetime occupational radiation exposure.
15552099 - Midplane dose determination using in vivo dose measurements in combination with portal ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of refractive surgery (Thorofare, N.J. : 1995)     Volume:  14     ISSN:  1081-597X     ISO Abbreviation:  J Refract Surg     Publication Date:    1998 Jul-Aug
Date Detail:
Created Date:  1998-10-01     Completed Date:  1998-10-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9505927     Medline TA:  J Refract Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  447-54     Citation Subset:  IM    
Affiliation:
Helsinki University, Eye Hospital, Finland. minna.vesaluoma@huch.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cornea / surgery*
Female
Growth Substances / metabolism*
Humans
Immunoassay
Lasers, Excimer
Male
Middle Aged
Photorefractive Keratectomy*
Refractive Surgical Procedures*
Tears / metabolism*
Tenascin / metabolism*
Time Factors
Wound Healing
Chemical
Reg. No./Substance:
0/Growth Substances; 0/Tenascin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Results of photorefractive keratectomy for low, moderate, and high myopia.
Next Document:  Stability of astigmatism over 3 years after corneal stretch incision.